JOHNSON & JOHNSON

Trading Ideas Johnson & Johnson

Equities

JNJ

US4781601046

Pharmaceuticals

Market Closed - Nyse Other stock markets 04:00:02 2025-01-17 pm EST			5-day change	1st Jan Change
147.03 ^USD	-0.50%		+1.77%	+1.67%

Jan. 20	Sumitomo Pharma Co., Ltd. Announces Agreement on Co-Promotion Collaboration Partner for Marketing of Pplat Xeplion and Xeplion Trial in Japan with Johnson & Johnson	CI
Jan. 17	S&P 500 Logs 2.9% Weekly Gain on Easing Inflationary Pressures, Strong Bank Earnings	MT

Trading Ideas

JOHNSON & JOHNSON: An end to the technical rebound lies ahead	19-11-27
JOHNSON & JOHNSON: The underlying trend is to the upside	17-06-12
JOHNSON & JOHNSON: Expect the comeback of a strong trend	17-05-10
JOHNSON & JOHNSON: Buying pressure	16-12-22
JOHNSON & JOHNSON: A good level to buy	16-09-12
JOHNSON & JOHNSON: Towards historic highs	12-09-26
JOHNSON & JOHNSON: Beginning of a bearish movement	12-06-26

Become a member to access more news.

100% Free Registration

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

J&J to Buy Intra-Cellular for About $14 Billion

J&J to Buy Intra-Cellular for About $14 Billion

January 13, 2025 at 12:32 pm EST